BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 36534892)

  • 1. COVID-19-related uncertainty: fertility staff experiences of its sources, processing, responses, and consequences.
    Gameiro S; Armstrong K; Carluke N; Baccino G; Zegers-Hochschild F; Boivin J
    Hum Reprod; 2023 Feb; 38(2):247-255. PubMed ID: 36534892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient experiences of fertility clinic closure during the COVID-19 pandemic: appraisals, coping and emotions.
    Boivin J; Harrison C; Mathur R; Burns G; Pericleous-Smith A; Gameiro S
    Hum Reprod; 2020 Nov; 35(11):2556-2566. PubMed ID: 32761248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative evaluation of the acceptability and feasibility among healthcare professionals and patients of an ART multi-cycle treatment planning and continuation intervention prototype.
    Harrison C; Gameiro S; Boivin J
    Hum Reprod; 2023 Mar; 38(3):430-443. PubMed ID: 36637254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discussing the possibility of fertility treatment being unsuccessful as part of routine care offered at clinics: patients' experiences, willingness, and preferences.
    Sousa-Leite M; Costa R; Figueiredo B; Gameiro S
    Hum Reprod; 2023 Jul; 38(7):1332-1344. PubMed ID: 37196325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is bad news in fertility care? A qualitative analysis of staff and patients' accounts of bad and challenging news in fertility care.
    Gameiro S; Adcock E; Graterol Munoz C; O'Hanrahan M; D'Angelo A; Boivin J
    Hum Reprod; 2024 Jan; 39(1):139-146. PubMed ID: 37968233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Top 10 priorities for future infertility research: an international consensus development study†  ‡.
    Duffy JMN; Adamson GD; Benson E; Bhattacharya S; Bhattacharya S; Bofill M; Brian K; Collura B; Curtis C; Evers JLH; Farquharson RG; Fincham A; Franik S; Giudice LC; Glanville E; Hickey M; Horne AW; Hull ML; Johnson NP; Jordan V; Khalaf Y; Knijnenburg JML; Legro RS; Lensen S; MacKenzie J; Mavrelos D; Mol BW; Morbeck DE; Nagels H; Ng EHY; Niederberger C; Otter AS; Puscasiu L; Rautakallio-Hokkanen S; Sadler L; Sarris I; Showell M; Stewart J; Strandell A; Strawbridge C; Vail A; van Wely M; Vercoe M; Vuong NL; Wang AY; Wang R; Wilkinson J; Wong K; Wong TY; Farquhar CM; ; AlAhwany H; Balaban O; Barton F; Beebeejaun Y; Boivin J; Bosteels JJA; Calhaz-Jorge C; D’Angelo A; F. Dann L; J. De Jonge C; du Mez E; A. Ferriani R; Gerval MO; J. Gingel L; Greenblatt EM; Hartshorne G; Helliwell C; Hughes LJ; Jo J; Jovanović J; Kiesel L; Kietpeerakool C; Kostova E; Kucuk T; Kumar R; Lawrence RL; Lee N; Lindemann KE; Loto OM; Lutjen PJ; MacKinven M; Mascarenhas M; McLaughlin H; Mourad SM; Nguyen LK; Norman RJ; Olic M; Overfield KL; Parker-Harris M; Repping S; Rizzo R; Salacone P; Saunders CH; Sengupta R; Sfontouris IA; Silverman NR; Torrance HL; Uphoff EP; Wakeman SA; Wischmann T; Woodward BJ; Youssef MA
    Hum Reprod; 2020 Dec; 35(12):2715-2724. PubMed ID: 33252677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top 10 priorities for future infertility research: an international consensus development study.
    Duffy JMN; Adamson GD; Benson E; Bhattacharya S; Bhattacharya S; Bofill M; Brian K; Collura B; Curtis C; Evers JLH; Farquharson RG; Fincham A; Franik S; Giudice LC; Glanville E; Hickey M; Horne AW; Hull ML; Johnson NP; Jordan V; Khalaf Y; Knijnenburg JML; Legro RS; Lensen S; MacKenzie J; Mavrelos D; Mol BW; Morbeck DE; Nagels H; Ng EHY; Niederberger C; Otter AS; Puscasiu L; Rautakallio-Hokkanen S; Sadler L; Sarris I; Showell M; Stewart J; Strandell A; Strawbridge C; Vail A; van Wely M; Vercoe M; Vuong NL; Wang AY; Wang R; Wilkinson J; Wong K; Wong TY; Farquhar CM;
    Fertil Steril; 2021 Jan; 115(1):180-190. PubMed ID: 33272617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Talking about possible IVF/ICSI failure and need for multiple cycles in treatment planning: qualitative investigation of multi-cycle planning and its acceptability to patients and staff.
    Harrison C; Boivin J; Gameiro S
    Hum Reprod; 2022 Mar; 37(3):488-498. PubMed ID: 35040994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
    Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient willingness, preferences and decision-making about planning for three complete cycles of IVF/ICSI treatment.
    Harrison C; Gameiro S; Boivin J
    Hum Reprod; 2021 Apr; 36(5):1339-1352. PubMed ID: 33744926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESHRE guideline: endometriosis.
    Becker CM; Bokor A; Heikinheimo O; Horne A; Jansen F; Kiesel L; King K; Kvaskoff M; Nap A; Petersen K; Saridogan E; Tomassetti C; van Hanegem N; Vulliemoz N; Vermeulen N;
    Hum Reprod Open; 2022; 2022(2):hoac009. PubMed ID: 35350465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility randomized controlled trial of a self-guided online intervention to promote psychosocial adjustment to unmet parenthood goals.
    Rowbottom B; Galhardo A; Donovan E; Gameiro S
    Hum Reprod; 2022 Sep; 37(10):2412-2425. PubMed ID: 36001052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good practice recommendations on add-ons in reproductive medicine†.
    ; Lundin K; Bentzen JG; Bozdag G; Ebner T; Harper J; Le Clef N; Moffett A; Norcross S; Polyzos NP; Rautakallio-Hokkanen S; Sfontouris I; Sermon K; Vermeulen N; Pinborg A
    Hum Reprod; 2023 Nov; 38(11):2062-2104. PubMed ID: 37747409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESHRE guideline: ovarian stimulation for IVF/ICSI
    Ovarian Stimulation TEGGO; Bosch E; Broer S; Griesinger G; Grynberg M; Humaidan P; Kolibianakis E; Kunicki M; La Marca A; Lainas G; Le Clef N; Massin N; Mastenbroek S; Polyzos N; Sunkara SK; Timeva T; Töyli M; Urbancsek J; Vermeulen N; Broekmans F
    Hum Reprod Open; 2020; 2020(2):hoaa009. PubMed ID: 32395637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometriosis classification systems: an international survey to map current knowledge and uptake.
    ; Zondervan KT; Missmer S; Abrao MS; Einarsson JI; Horne AW; Johnson NP; Lee TTM; Petrozza J; Tomassetti C; Vermeulen N; Grimbizis G; De Wilde RL
    Hum Reprod Open; 2022; 2022(1):hoac002. PubMed ID: 35237731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
    Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived challenges of working in a fertility clinic: a qualitative analysis of work stressors and difficulties working with patients.
    Boivin J; Bunting L; Koert E; Ieng U C; Verhaak C
    Hum Reprod; 2017 Feb; 32(2):403-408. PubMed ID: 28057875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.
    Katalinic A; Noftz MR; Garcia-Velasco JA; Shulman LP; van den Anker JN; Strauss Iii JF
    Hum Reprod Open; 2024; 2024(1):hoae004. PubMed ID: 38344249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.